Bayer Aktiengesellschaft (OTCMKTS:BAYRY) Shares Gap Down – Here’s Why

by · The Markets Daily

Shares of Bayer Aktiengesellschaft (OTCMKTS:BAYRY – Get Free Report) gapped down prior to trading on Tuesday. The stock had previously closed at $14.46, but opened at $13.92. Bayer Aktiengesellschaft shares last traded at $13.8810, with a volume of 22,926 shares.

Analyst Ratings Changes

Several equities analysts have commented on the stock. Zacks Research raised shares of Bayer Aktiengesellschaft from a “hold” rating to a “strong-buy” rating in a research note on Friday, July 10th. Deutsche Bank Aktiengesellschaft raised shares of Bayer Aktiengesellschaft from a “hold” rating to a “buy” rating in a research note on Thursday, July 2nd. Two equities research analysts have rated the stock with a Strong Buy rating, five have issued a Buy rating and one has given a Hold rating to the company’s stock. According to MarketBeat.com, the company has a consensus rating of “Buy”.

Get Our Latest Stock Report on BAYRY

Bayer Aktiengesellschaft Price Performance

The company has a fifty day simple moving average of $14.02 and a 200-day simple moving average of $12.47. The company has a market cap of $54.59 billion, a P/E ratio of -27.24, a PEG ratio of 2.15 and a beta of 0.56. The company has a debt-to-equity ratio of 1.05, a current ratio of 1.04 and a quick ratio of 0.67.

Bayer Aktiengesellschaft (OTCMKTS:BAYRY – Get Free Report) last released its quarterly earnings data on Tuesday, August 4th. The company reported $0.29 earnings per share for the quarter, topping the consensus estimate of $0.23 by $0.06. Bayer Aktiengesellschaft had a positive return on equity of 16.77% and a negative net margin of 3.80%.The business had revenue of $12.53 billion during the quarter, compared to analyst estimates of $12.31 billion. Bayer Aktiengesellschaft has set its FY 2026 guidance at 1.200-1.346 EPS. On average, sell-side analysts predict that Bayer Aktiengesellschaft will post 1.28 earnings per share for the current year.

About Bayer Aktiengesellschaft

(Get Free Report)

Bayer Aktiengesellschaft is a Germany-based life science company focused on health care and agriculture. Through its Pharmaceuticals, Consumer Health and Crop Science businesses, the company develops and markets products intended to improve human health, everyday self-care and agricultural productivity.

Bayer’s Pharmaceuticals business provides prescription medicines in areas such as cardiovascular disease, women’s health, oncology and specialty medicine. Its Consumer Health division offers nonprescription products in categories including pain relief, nutritional supplements, dermatology and allergy care, with brands such as Aspirin and Claritin.

Read More